Atrial fibrillation: new theories, emerging treatments.
Johnson
Johnna
J
Emory University School of Medicine Physician Assistant Program, Atlanta, GA, USA.
Napier
Kevin T
KT
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D017115:Catheter Ablation; D002986:Clinical Trials as Topic; D004554:Electric Countershock; D022062:Electrophysiologic Techniques, Cardiac; D006801:Humans; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants